Effekt der additiven Boost-Bestrahlung bei der Radiotherapie nach brusterhaltender Operation des frühen Mammakarzinoms20-Jahres-Daten der EORTC-StudieEffect of radiation boost in whole-breast irradiation after breast-conserving surgery for early breast cancerThe 20-year follow-up data of the EORTC trial

被引:0
|
作者
Kirsten Eilf
Jürgen Dunst
机构
[1] Karl-Lennert-Krebscentrum,Praxis für Strahlentherapie/Klinik für Strahlentherapie
[2] UK S-H/Campus Kiel,undefined
关键词
D O I
10.1007/s00066-015-0844-0
中图分类号
学科分类号
摘要
引用
收藏
页码:613 / 615
页数:2
相关论文
共 3 条
  • [1] Whole-breast irradiation with or without a boost for patients treated with breast-conserving surgery for early breast cancer: 20-year follow-up of a randomised phase 3 trial
    Bartelink, Harry
    Maingon, Philippe
    Poortmans, Philip
    Weltens, Caroline
    Fourquet, Alain
    Jager, Jos
    Schinagl, Dominic
    Oei, Bing
    Rodenhuis, Carla
    Horiot, Jean-Claude
    Struikmans, Henk
    Van Limbergen, Erik
    Kirova, Youlia
    Elkhuizen, Paula
    Bongartz, Rudolf
    Miralbell, Raymond
    Morgan, David
    Dubois, Jean-Bernard
    Remouchamps, Vincent
    Mirimanoff, Rene-Olivier
    Collette, Sandra
    Collette, Laurence
    LANCET ONCOLOGY, 2015, 16 (01): : 47 - 56
  • [2] Whole-breast irradiation with or without a boost for patients treated with breast-conserving surgery for early breast cancer: 20-year follow-up of a randomised phase 3 trial (vol16, pg 47, 2015)
    Bartelink, H.
    Maingon
    Poortmans, P.
    LANCET ONCOLOGY, 2015, 16 (01): : E6 - E6
  • [3] Intraoperative Teilbrustbestrahlung mit Elektronen (ELIOT) vs. konventionelle Ganzbrustbestrahlung beim invasiven Mammakarzinom im frühen Stadium nach brusterhaltender Operation: Langzeitdaten einer kontrollierten, randomisierten StudieIntraoperative partial breast irradiation with electrons (ELIOT) compared to conventionally fractionated whole-breast irradiation of early-stage invasive breast cancer after breast-conserving surgery: long-term data from a prospective randomised trial
    Gerd Fastner
    Roland Reitsamer
    Christoph Gaisberger
    Markus Stana
    Felix Sedlmayer
    Strahlentherapie und Onkologie, 2021, 197 (11) : 1032 - 1036